Nebulized fentanyl for palliation of dyspnea in a cystic fibrosis patient

Gavin Graff, James M. Stark, Ryan Grueber

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Dyspnea, the subjective symptom feeling of breathlessness, is a common symptom in terminally ill patients with cystic fibrosis (CF). The palliation of the dyspnea is a reasonable goal to improve patient comfort as the progression of the disease worsens. We report the successful use of inhaled fentanyl for 3 days in a 17-year-old female with terminal CF lung disease, as measured by improved oxygenation and a reduction in the modified Borg score, and the subjective feeling of less air hunger reported by parents and patient.

Original languageEnglish (US)
Pages (from-to)646-649
Number of pages4
JournalRespiration
Volume71
Issue number6
DOIs
StatePublished - Dec 1 2004

Fingerprint

Fentanyl
Cystic Fibrosis
Dyspnea
Emotions
Terminally Ill
Hunger
Lung Diseases
Disease Progression
Parents
Air

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine

Cite this

Graff, Gavin ; Stark, James M. ; Grueber, Ryan. / Nebulized fentanyl for palliation of dyspnea in a cystic fibrosis patient. In: Respiration. 2004 ; Vol. 71, No. 6. pp. 646-649.
@article{8c379b0c6f14415fa6a267096d8a5faa,
title = "Nebulized fentanyl for palliation of dyspnea in a cystic fibrosis patient",
abstract = "Dyspnea, the subjective symptom feeling of breathlessness, is a common symptom in terminally ill patients with cystic fibrosis (CF). The palliation of the dyspnea is a reasonable goal to improve patient comfort as the progression of the disease worsens. We report the successful use of inhaled fentanyl for 3 days in a 17-year-old female with terminal CF lung disease, as measured by improved oxygenation and a reduction in the modified Borg score, and the subjective feeling of less air hunger reported by parents and patient.",
author = "Gavin Graff and Stark, {James M.} and Ryan Grueber",
year = "2004",
month = "12",
day = "1",
doi = "10.1159/000081769",
language = "English (US)",
volume = "71",
pages = "646--649",
journal = "Respiration; international review of thoracic diseases",
issn = "0025-7931",
publisher = "S. Karger AG",
number = "6",

}

Nebulized fentanyl for palliation of dyspnea in a cystic fibrosis patient. / Graff, Gavin; Stark, James M.; Grueber, Ryan.

In: Respiration, Vol. 71, No. 6, 01.12.2004, p. 646-649.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Nebulized fentanyl for palliation of dyspnea in a cystic fibrosis patient

AU - Graff, Gavin

AU - Stark, James M.

AU - Grueber, Ryan

PY - 2004/12/1

Y1 - 2004/12/1

N2 - Dyspnea, the subjective symptom feeling of breathlessness, is a common symptom in terminally ill patients with cystic fibrosis (CF). The palliation of the dyspnea is a reasonable goal to improve patient comfort as the progression of the disease worsens. We report the successful use of inhaled fentanyl for 3 days in a 17-year-old female with terminal CF lung disease, as measured by improved oxygenation and a reduction in the modified Borg score, and the subjective feeling of less air hunger reported by parents and patient.

AB - Dyspnea, the subjective symptom feeling of breathlessness, is a common symptom in terminally ill patients with cystic fibrosis (CF). The palliation of the dyspnea is a reasonable goal to improve patient comfort as the progression of the disease worsens. We report the successful use of inhaled fentanyl for 3 days in a 17-year-old female with terminal CF lung disease, as measured by improved oxygenation and a reduction in the modified Borg score, and the subjective feeling of less air hunger reported by parents and patient.

UR - http://www.scopus.com/inward/record.url?scp=11844280942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11844280942&partnerID=8YFLogxK

U2 - 10.1159/000081769

DO - 10.1159/000081769

M3 - Article

C2 - 15627879

AN - SCOPUS:11844280942

VL - 71

SP - 646

EP - 649

JO - Respiration; international review of thoracic diseases

JF - Respiration; international review of thoracic diseases

SN - 0025-7931

IS - 6

ER -